Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yetmen Dogan, O."'
Publikováno v:
In ESMO Open February 2023 8(1) Supplement 1
Lapatinib is an oral receptor tyrosine kinase inhibitor which has shown activity in the treatment of metastatic breast cancer. There is no data regarding the side effects of combination of radiotherapy and Lapatinib. 40 female Wistar-albino rats (WAR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10007::1a2b1a6a0e2fcd9f93ae660fb6801313
https://hdl.handle.net/20.500.11831/4301
https://hdl.handle.net/20.500.11831/4301
Lapatinib is an oral receptor tyrosine kinase inhibitor which has shown activity in the treatment of metastatic breast cancer. There is no data regarding the side effects of combination of radiotherapy and Lapatinib. 40 female Wistar-albino rats (WAR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56bd8ad250a1d24173549e042b1918d0
https://hdl.handle.net/11443/2517
https://hdl.handle.net/11443/2517